Innate Immunity and Pathology of the Critical patient

Rafael Mañez Mendiluce

PRINCIPAL INVESTIGATORS
  • Joan Sabater Riera
CLINICAL RESEARCHERS
  • Luisa Corral Ansa
  • Francesc Esteve Urbano
  • Mª Paz Fuset Cabanes
  • Juan Carlos López Delgado
  • Gabriel Jesus Moreno González
  • Ana Ochagavia Calvo
  • Eva Oliver Juan
  • Xosé Luis Pérez Fernández
POSTDOCTORAL RESEARCHERS
  • Sara Olivera Ardid
PREDOCTORAL RESEARCHERS
  • Ricard Soley Corderas
  • Victor Daniel Gumucio Sanguino
Translational Medicine
Infectious disease and transplantation

Scientific production

21

PAPERS

Average IF: 7,625

7

LED PAPERS

Average IF: 19,045

2 PUBLICATIONS IN FIRST DECILE

10 PUBLICATIONS IN FIRST QUARTILE

18 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Senage T, Paul A, Le Tourneau T, Fellah Hebia I, Vadori M, Bashir S, Galinanes M, Bottio T, Gerosa G, Evangelista A, Badano LP, Nassi A, Costa C, Cesare G, Manji RA, de Monchy CC, Piriou N, Capoulade R, Serfaty JM, Guimbretiere G, Dantan E, Ruiz Majoral A, du Fou GC, Ben Arye SL, Govani L, Yehuda S, Abramovitch SB, Amon R, Reuven EM, Atiya Nasagi Y, Yu H, Iop L, Casos K, Kuguel SG, Blasco Lucas A, Permanyer E, Sbraga F, Llatjos R, Moreno Gonzalez G, Sanchez Martinez M, Breimer ME, Holgersson J, Teneberg S, Pascual Gilabert M, Nonell Canals A, Takeuchi Y, Chen X, Manez R, Roussel JC, Soulillou JP, Cozzi E, Padler Karavani V. The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration. Nat. Med. 2022;28(2):283-294. doi:10.1038/s41591-022-01682-w.
  • Torres A, Motos A, Cillóniz C, Ceccato A, Fernández Barat L, Gabarrús A, Bermejo Martin J, Ferrer R, Riera J, Pérez Arnal R, García Gasulla D, Peñuelas O, Lorente JÁ, de Gonzalo Calvo D, Almansa R, Menéndez R, Palomeque A, Villar RA, Añón JM, Balan Mariño A, Barberà C, Barberán J, Blandino Ortiz A, Boado MV, Bustamante Munguira E, Caballero J, Cantón Bulnes ML, Carbajales Pérez C, Carbonell N, Catalán González M, de Frutos R, Franco N, Galbán C, Gumucio Sanguino VD, de la Torre MDC, Díaz E, Estella Á, Gallego E, García Garmendia JL, Gómez JM, Huerta A, García RNJ, Loza Vázquez A, Marin Corral J, Martin Delgado MC, Martínez de la Gándara A, Martínez Varela I, López Messa J, Albaiceta GM, Nieto M, Novo MA, Peñasco Y, Pérez García F, Pozo Laderas JC, Ricart P, Sagredo V, Sánchez Miralles A, Sancho Chinesta S, Serra Fortuny M, Socias L, Solé Violan J, Suarez Sipmann F, Tamayo Lomas L, Trenado J, Úbeda A, Valdivia LJ, Vidal P, Barbé F, CIBERESUCICOVID Project I. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study. Intensive Care Med. 2022;48(7):1-15. doi:10.1007/s00134-022-06726-w.
  • Wendel Garcia PD, Mas A, Gonzalez Isern C, Ferrer R, Manez R, Masclans JR, Sandoval E, Vera P, Trenado J, Fernandez R, Sirvent JM, Martinez M, Ibarz M, Garro P, Lopera JL, Bodi M, Yebenes Reyes JC, Triginer C, Vallverdu I, Baro A, Bodi F, Saludes P, Valencia M, Roche Campo F, Huerta A, Cambra FJ, Barbera C, Echevarria J, Penuelas O, Mancebo J, UCIsCAT Study GRP. Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective study. Crit. Care. 2022;26(1):doi:10.1186/s13054-022-03905-5.
  • Olivera Ardid S, Bello Gil D, Tuzikov A, Araujo RN, Ferrero Alves Y, García Figueroa BE, Labrador Horrillo M, García Pérez AL, Bovin N, Mañez R. Poly-L-Lysine-Based aGal-Glycoconjugates for Treating Anti-aGal IgE-Mediated Diseases. Front. Immunol. 2022;13873019-873019. doi:10.3389/fimmu.2022.873019.
  • Lopez Delgado JC, Grau Carmona T, Trujillano Cabello J, García Fuentes C, Mor Marco E, Bordeje Laguna ML, Portugal Rodriguez E, Lorencio Cardenas C, Vera Artazcoz P, Macaya Redin L, Martinez Carmona JF, Mateu Campos L, Gero Escapa M, Gastaldo Simeon R, Vila García B, Flordelis Lasierra JL, Montejo Gonzalez JC, Servia Goixart L, The Enpic Study G. The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes?. Nutrients. 2022;14(9):doi:10.3390/nu14091904.

Research highlights

PROJECTS

4 Ongoing competitive projects
6 Non-competitive project

3 Started clinical trials
8 ongoing clinical trials

PUBLISHED WORKS

1 Thesis

INNOVATION

1 Patent
2 Licenses
1 spin-off 

Selected projects

  • 18ACL237. Estudio de fase 3, aleatorizado, doble ciego y controlado con placebo, para evaluar la eficacia y la seguridad de qpi-1002 en la prevención de acontecimientos adversos renales graves (make) en pacientes con alto riesgo de lesión renal aguda (aki) después de cirugía cardíaca. Budget: 545700. 2018- . PI: Sabater Riera, Joan.
  • 20PSJ007. A breakthrough alternative to antibiotics for curing bacterial infectious disease. FUNDACIÓ “LA CAIXA”. Budget: 300000. 2020-2022. PI: Máñez Mendiluce, Rafael.
  • 17INT001. Increased adsorption membranes during cardiopulmonary bypass. A randomized controlled trial to evaluate impact in postsurgical acute kidney injury. BAXTER HEALTHCARE CORPORATION. Budget: 207425,35. 2017-2022. PI: Pérez Fernández, Xosé Luis.
  • 20CEE013. ENVISION: Intelligent plug-and-play digital tool for real-time surveillance of COVID-19 patients and smart decision-making in Intensive Care Units. COMISSIÓ EUROPEA. Budget: 115000. 2020-2023. PI: Máñez Mendiluce, Rafael.20ACL009. OBSERVATIONAL COHORT STUDY TO CHARACTERISE THE CURRENT USE OF PARENTERAL NUTRITION AND CLINICAL OUTCOMES IN ADULT CRITICALLY ILL PATIENTS HOSPITALISED IN INTENSIVE CARE UNITS IN EUROPE. Budget: 103968. 2020- . PI: López Delgado, Juan Carlos.